CLINICAL_TRIALS
trial_result
· 2019-07-02
Clinical Trial Update: Study on Cerebral Protection of Dexmedetomidine for Patients With Traumatic Brain Injury [Phase 4]
Summary
A Phase 4 trial assessing cerebral protection with dexmedetomidine in patients with traumatic brain injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xiangya Hospital of Central South University | Conditions: Traumatic Brain Injury | Phase 4 | Status: UNKNOWN